|
|
||||||||
The Journal of Immunology, Vol 156, Issue 7 2384-2390, Copyright © 1996 by American Association of Immunologists
ARTICLES |
Y Geng, SM Savage, S Razanai-Boroujerdi and ML Sopori
Immunotoxicology Section, Insitute of Basic and Applied Medical Research, The Lovelace Insitutes, Albuquerque, NM 87108, USA.
Previously, we have shown that both T and B lymphocytes from chronically nicotine-treated (NT) animals exhibit tolerance to activation by Ags (ligation of Ag receptors), as indicated by their decreased ability to mobilize intracellular calcium and, at least in T cells, arrest of cells in the G0/G1 phase of the cell cycle. Herein, we demonstrate that NT T cells significantly lose their ability to up- regulate inositol trisphosphate synthesis in response to TCR ligation or nonspecific activation of G proteins by AIF-4. However, increases in cAMP concentrations of T cells following activation of G protein- sensitive adenylate cyclase by cholera or pertussis toxin were not significantly affected by the nicotine treatment. Interestingly, compared with control T cells, the background levels of inositol trisphosphate were significantly elevated in NT T cells, indicating some degree of activation in these cells. This inference was further supported by observations that naive T cells from NT animals exhibit tyrosine phosphorylation of several substrates, including phospholipase C-gamma1, which were either absent or underphosphorylated in unstimulated control T cells. Moreover, when, after 4-wk nicotine treatment, nicotine pumps were removed and serum cotinine levels fell to background, inhibition of the Ab-forming cells and Ca2+ responses continued for at least 2 more wk. These results suggest that chronic in vivo nicotine exposure leads to T cell anergy and may contribute to nicotine/cigarette smoke-induced immunosuppression.
This article has been cited by other articles:
![]() |
N. C. Mishra, J. Rir-sima-ah, R. J. Langley, S. P. Singh, J. C. Pena-Philippides, T. Koga, S. Razani-Boroujerdi, J. Hutt, M. Campen, K. C. Kim, et al. Nicotine Primarily Suppresses Lung Th2 but Not Goblet Cell and Muscle Cell Responses to Allergens J. Immunol., June 1, 2008; 180(11): 7655 - 7663. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yang, T. Sun, L. Wang, D. Yu, X. Zhang, X. Miao, J. Liu, D. Zhao, H. Li, W. Tan, et al. Functional Variants in Cell Death Pathway Genes and Risk of Pancreatic Cancer Clin. Cancer Res., May 15, 2008; 14(10): 3230 - 3236. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Razani-Boroujerdi, R. T. Boyd, M. I. Davila-Garcia, J. S. Nandi, N. C. Mishra, S. P. Singh, J. C. Pena-Philippides, R. Langley, and M. L. Sopori T Cells Express {alpha}7-Nicotinic Acetylcholine Receptor Subunits That Require a Functional TCR and Leukocyte-Specific Protein Tyrosine Kinase for Nicotine-Induced Ca2+ Response J. Immunol., September 1, 2007; 179(5): 2889 - 2898. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-R. Blanchet, A. Langlois, E. Israel-Assayag, M.-J. Beaulieu, C. Ferland, M. Laviolette, and Y. Cormier Modulation of eosinophil activation in vitro by a nicotinic receptor agonist J. Leukoc. Biol., May 1, 2007; 81(5): 1245 - 1251. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cloez-Tayarani and J.-P. Changeux Nicotine and serotonin in immune regulation and inflammatory processes: a perspective J. Leukoc. Biol., March 1, 2007; 81(3): 599 - 606. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. R. Gritz, C. Dresler, and L. Sarna Smoking, The Missing Drug Interaction in Clinical Trials: Ignoring the Obvious Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2287 - 2293. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Rubin, T. M. Hermanson, E. J. Bedrick, J. D. McDonald, S. W. Burchiel, M. D. Reed, and W. L. Sibbitt Jr. Effect of Cigarette Smoke on Autoimmunity in Murine and Human Systemic Lupus Erythematosus Toxicol. Sci., September 1, 2005; 87(1): 86 - 96. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Vassallo, K. Tamada, J. S. Lau, P. R. Kroening, and L. Chen Cigarette Smoke Extract Suppresses Human Dendritic Cell Function Leading to Preferential Induction of Th-2 Priming J. Immunol., August 15, 2005; 175(4): 2684 - 2691. [Abstract] [Full Text] [PDF] |
||||
![]() |
G H Bothamley Smoking and tuberculosis: a chance or causal association? Thorax, July 1, 2005; 60(7): 527 - 528. [Full Text] [PDF] |
||||
![]() |
L. Arcavi and N. L. Benowitz Cigarette Smoking and Infection Arch Intern Med, November 8, 2004; 164(20): 2206 - 2216. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Frazer-Abel, S. Baksh, S. P. Fosmire, D. Willis, A. M. Pierce, H. Meylemans, D. S. Linthicum, S. J. Burakoff, T. Coons, D. Bellgrau, et al. Nicotine Activates Nuclear Factor of Activated T Cells c2 (NFATc2) and Prevents Cell Cycle Entry in T Cells J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 758 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Laan, S. Bozinovski, and G. P. Anderson Cigarette Smoke Inhibits Lipopolysaccharide-Induced Production of Inflammatory Cytokines by Suppressing the Activation of Activator Protein-1 in Bronchial Epithelial Cells J. Immunol., September 15, 2004; 173(6): 4164 - 4170. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kalra, S. P. Singh, J. C. Pena-Philippides, R. J. Langley, S. Razani-Boroujerdi, and M. L. Sopori Immunosuppressive and Anti-Inflammatory Effects of Nicotine Administered by Patch in an Animal Model Clin. Vaccine Immunol., May 1, 2004; 11(3): 563 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Stagnaro, R. Tumino, S. Parodi, P. Crosignani, A. Fontana, G. Masala, L. Miligi, O. Nanni, V. Ramazzotti, S. Rodella, et al. Non-Hodgkin's Lymphoma and Type of Tobacco Smoke Cancer Epidemiol. Biomarkers Prev., March 1, 2004; 13(3): 431 - 437. [Abstract] [Full Text] |
||||
![]() |
H. Friedman, C. Newton, and T. W. Klein Microbial Infections, Immunomodulation, and Drugs of Abuse Clin. Microbiol. Rev., April 1, 2003; 16(2): 209 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Middlebrook, C. Martina, Y. Chang, R. J. Lukas, and D. DeLuca Effects of Nicotine Exposure on T Cell Development in Fetal Thymus Organ Culture: Arrest of T Cell Maturation J. Immunol., September 15, 2002; 169(6): 2915 - 2924. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kalra, S. P. Singh, D. Kracko, S. G. Matta, B. M. Sharp, and M. L. Sopori Chronic Self-Administration of Nicotine in Rats Impairs T Cell Responsiveness J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 935 - 939. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. DAHMEN, T. PAULY, A. SZEGEDI, H. WETZEL, I. ANGHELESCU, K. FERDINAND, and C. HIEMKE ADENYLYL CYCLASE ACTIVITY IS INCREASED IN YOUNGER, BUT DECREASED IN OLDER, ALCOHOLIC PATIENTS AFTER DETOXIFICATION Alcohol Alcohol., May 1, 2000; 35(3): 249 - 254. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Geng, K. Berencsi, Z. Gyulai, T. Valyi-Nagy, E. Gonczol, and G. Trinchieri Roles of Interleukin-12 and Gamma Interferon in Murine Chlamydia pneumoniae Infection Infect. Immun., April 1, 2000; 68(4): 2245 - 2253. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kalra, S. P. Singh, S. M. Savage, G. L. Finch, and M. L. Sopori Effects of Cigarette Smoke on Immune Response: Chronic Exposure to Cigarette Smoke Impairs Antigen-Mediated Signaling in T Cells and Depletes IP3-Sensitive Ca2+ Stores J. Pharmacol. Exp. Ther., April 1, 2000; 293(1): 166 - 171. [Abstract] [Full Text] |
||||
![]() |
M. Laan, I. Qvarfordt, G. C Riise, B. A Andersson, S. Larsson, and A. Lindén Increased levels of interleukin-16 in the airways of tobacco smokers: relationship with peripheral blood T lymphocytes Thorax, October 1, 1999; 54(10): 911 - 916. [Abstract] [Full Text] |
||||
![]() |
D.-K. SONG, Y.-B. IM, J.-S. JUNG, H.-W. SUH, S.-O. HUH, J.-H. SONG, and Y.-H. KIM Central injection of nicotine increases hepatic and splenic interleukin 6 (IL-6) mRNA expression and plasma IL-6 levels in mice: involvement of the peripheral sympathetic nervous system FASEB J, July 1, 1999; 13(10): 1259 - 1267. [Abstract] [Full Text] |
||||
![]() |
K. Edwards, K. M Braun, G. Evans, A. O Sureka, and S. Fan Mainstream and sidestream cigarette smoke condensates suppress macrophage responsiveness to interferony Human and Experimental Toxicology, April 1, 1999; 18(4): 233 - 240. [Abstract] [PDF] |
||||
![]() |
S. Razani-Boroujerdi, B. Edwards, and M. L. Sopori Lead Stimulates Lymphocyte Proliferation Through Enhanced T Cell-B Cell Interaction J. Pharmacol. Exp. Ther., February 1, 1999; 288(2): 714 - 719. [Abstract] [Full Text] |
||||
![]() |
H. Melhus, V. Herbert, S. N. Meydani, M. Meydani, L. S. Leka, and J. B. Blumberg Vitamin E Supplementation and Immune Response in Elderly Patients JAMA, February 18, 1998; 279(7): 505 - 506. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |